Careers

Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism.
NASDAQ: AGIO$123.70 Stock is Up 1.48 (1.21%)

UPCOMING EVENTS

Read more
Friday, June 12, 2015 8:00 a.m. ET
Agios EHA Conference Call

CONTACTS

Investor Inquiries:
General inquiries: investors@agios.com

Institutional Investors and Financial Analysts:
Renee Leck
617-649-8299
renee.leck@agios.com

Media Inquiries:
Dan Budwick
Pure Communications
973-271-6085